ATE296891T1 - Protein tyrosin-phosphatasen von hematopoietischen zellen - Google Patents

Protein tyrosin-phosphatasen von hematopoietischen zellen

Info

Publication number
ATE296891T1
ATE296891T1 AT97916257T AT97916257T ATE296891T1 AT E296891 T1 ATE296891 T1 AT E296891T1 AT 97916257 T AT97916257 T AT 97916257T AT 97916257 T AT97916257 T AT 97916257T AT E296891 T1 ATE296891 T1 AT E296891T1
Authority
AT
Austria
Prior art keywords
nucleic acid
ptp
protein tyrosine
tyrosine phosphatases
hscs
Prior art date
Application number
AT97916257T
Other languages
English (en)
Inventor
Laurence A Lasky
Jill Cheng
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE296891T1 publication Critical patent/ATE296891T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97916257T 1996-03-22 1997-03-17 Protein tyrosin-phosphatasen von hematopoietischen zellen ATE296891T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62052696A 1996-03-22 1996-03-22
PCT/US1997/005278 WO1997035019A1 (en) 1996-03-22 1997-03-17 Protein tyrosine phosphatases of hematopoietic cells

Publications (1)

Publication Number Publication Date
ATE296891T1 true ATE296891T1 (de) 2005-06-15

Family

ID=24486323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97916257T ATE296891T1 (de) 1996-03-22 1997-03-17 Protein tyrosin-phosphatasen von hematopoietischen zellen

Country Status (10)

Country Link
EP (1) EP0906433B1 (de)
JP (1) JP3496938B2 (de)
AT (1) ATE296891T1 (de)
AU (1) AU719909B2 (de)
CA (1) CA2246430C (de)
DE (1) DE69733414T2 (de)
IL (1) IL125939A (de)
MX (1) MXPA98007322A (de)
WO (1) WO1997035019A1 (de)
ZA (1) ZA972446B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074589B1 (en) 1996-06-17 2006-07-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Nucleic acids encoding BDP-1
EP0914452A2 (de) * 1996-06-17 1999-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Ptp-20,pcp-2bdp1, clk und sirp proteine und verwandte produkte
US6004791A (en) 1996-11-13 1999-12-21 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Protein tyrosine phosphatase PTP20 and related products and methods
US6541615B1 (en) 1996-11-15 2003-04-01 Max-Planck-Gellschaft Zur Foderung Der Wissenschaften E.V. SIRP proteins and uses thereof
US6797513B2 (en) 1996-12-19 2004-09-28 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Nucleic acid encoding CLK2 protein kinases
CA2220853A1 (en) * 1998-01-16 1999-07-16 Hsc Research And Development Limited Partnership Human lymphoid protein tyrosine phosphatases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013989A1 (en) * 1990-03-14 1991-09-19 Washington Research Foundation Methods and compositions for the treatment of malignancies in which a protein kinase is associated

Also Published As

Publication number Publication date
DE69733414D1 (de) 2005-07-07
MXPA98007322A (es) 2004-08-24
AU719909B2 (en) 2000-05-18
AU2348297A (en) 1997-10-10
JP3496938B2 (ja) 2004-02-16
JP2000507104A (ja) 2000-06-13
IL125939A (en) 2008-06-05
CA2246430C (en) 2008-09-02
DE69733414T2 (de) 2006-04-27
IL125939A0 (en) 1999-04-11
CA2246430A1 (en) 1997-09-25
ZA972446B (en) 1998-09-21
EP0906433B1 (de) 2005-06-01
WO1997035019A1 (en) 1997-09-25
EP0906433A1 (de) 1999-04-07

Similar Documents

Publication Publication Date Title
Barry et al. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells
DE69735716D1 (de) Kappa/mu ähnliche proteintyrosinphosphatase, proteintyrosinphosphatase lambda
Lomonte et al. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo)
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
EA200000216A1 (ru) Белки, связывающие интерлейкин-18, их получение и применение
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
AR053063A2 (es) Proteina sustancialmente purificada y composicion farmaceutica que la comprende
BR9808545A (pt) ácido nucleico isolado, vetor de expressão, célula hospedeira, processos para produzir uma proteìna de ligação da osteoprotegerina, para detectar a presença de uma proteìna de ligação à osteoprotegerina em uma amostra biológica, para avaliar a capacidade de um composto candidato de ligar-se a uma proteìna de ligação da osteoprotegerina e de um composto de teste para aumentar ou reduzir a ligação da proteìna de ligação da osteoprotegerina a odar, para regular a expressão de uma proteìna de ligação da osteoprotegerina em um animal e para prevenir ou tratar de doença óssea em um mamìfero, polipeptìdeo, protéina de ligação da osteroprotegerina purificada e isolada, ou seu fragmento, análogo ou derivado, e, anticorpo ou seu fragmento
DE69838334D1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
Tedeschi et al. Purification and primary structure of a new bovine spermadhesin
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
ATE471986T1 (de) Verbesserung der homogenität und sekretion von rekombinanten proteinen in säugetiersystemen
Lee et al. Differential expression of cell surface proteins in human bone marrow mesenchymal stem cells cultured with or without basic fibroblast growth factor containing medium
Rasmussen et al. Two‐dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2
ES2173471T3 (es) Analisis para homocisteina y homocisteina desulfurasa a partir de tricomonas viginalis de protozoos.
DE69733414D1 (de) Protein tyrosin-phosphatasen von hematopoietischen zellen
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
Goldberger et al. NH2-terminal sequence analysis of pro-C4, the precursor of the fourth component of guinea pig complement.
Kerjan et al. Mammalian prolyl-tRNA synthetase corresponds to the≈ 150 kDa subunit of the high-Mr aminoacyl-tRNA synthetase complex
ATE86298T1 (de) Enzymatisch inaktive, immunologisch aktive beta- galactosidase-muteine.
EP1036164A4 (de) Chemokin alpha-5
BR9910725A (pt) Indução de proteìnas e peptìdeos antibióticos por proteìnas lait/s cd14
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung
Morgan et al. Complete covalent structure of human platelet factor 4
Carden et al. Chemical cross-linking analyses of ox neurofilaments

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties